Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by symbiont of host defense response (GO:0052031) | 6.67920565 |
2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.67920565 |
3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.67920565 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.67920565 |
5 | modulation by symbiont of host immune response (GO:0052553) | 6.67920565 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.67920565 |
7 | response to peptidoglycan (GO:0032494) | 5.96840972 |
8 | response to muramyl dipeptide (GO:0032495) | 5.27981570 |
9 | neutrophil activation involved in immune response (GO:0002283) | 5.09743848 |
10 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.93442235 |
11 | macrophage activation involved in immune response (GO:0002281) | 4.87809488 |
12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.70520893 |
13 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.62503198 |
14 | response to host immune response (GO:0052572) | 4.62503198 |
15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.54467396 |
16 | negative regulation of cell killing (GO:0031342) | 4.54467396 |
17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.47393359 |
18 | NIK/NF-kappaB signaling (GO:0038061) | 4.42675107 |
19 | positive regulation of interferon-alpha production (GO:0032727) | 4.30012457 |
20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.20952751 |
21 | positive regulation of heat generation (GO:0031652) | 4.18180520 |
22 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.17427988 |
23 | response to host (GO:0075136) | 4.12825148 |
24 | response to host defenses (GO:0052200) | 4.12825148 |
25 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.12825148 |
26 | regulation of interferon-alpha production (GO:0032647) | 4.10847513 |
27 | detection of molecule of bacterial origin (GO:0032490) | 4.01645280 |
28 | modulation by symbiont of host cellular process (GO:0044068) | 3.90673856 |
29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.86695619 |
30 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.84542528 |
31 | I-kappaB phosphorylation (GO:0007252) | 3.81469020 |
32 | microglial cell activation (GO:0001774) | 3.80943700 |
33 | natural killer cell mediated immunity (GO:0002228) | 3.79060902 |
34 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.79060902 |
35 | granulocyte activation (GO:0036230) | 3.76724566 |
36 | T-helper 1 type immune response (GO:0042088) | 3.76645404 |
37 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.74486197 |
38 | negative regulation of interleukin-12 production (GO:0032695) | 3.74115859 |
39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.73192878 |
40 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.73148437 |
41 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.71635235 |
42 | cell adhesion mediated by integrin (GO:0033627) | 3.71155913 |
43 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.70071190 |
44 | detection of bacterium (GO:0016045) | 3.69762357 |
45 | neutrophil activation (GO:0042119) | 3.67921472 |
46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.65828931 |
47 | immunoglobulin mediated immune response (GO:0016064) | 3.65673385 |
48 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.64595580 |
49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.62384544 |
50 | respiratory burst (GO:0045730) | 3.52887737 |
51 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.51657713 |
52 | neutrophil mediated immunity (GO:0002446) | 3.45332254 |
53 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.44600315 |
54 | regulation of fever generation (GO:0031620) | 3.44597457 |
55 | positive regulation of interleukin-12 production (GO:0032735) | 3.44022080 |
56 | detection of biotic stimulus (GO:0009595) | 3.43466176 |
57 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.42587107 |
58 | positive regulation of interferon-beta production (GO:0032728) | 3.42272216 |
59 | response to protozoan (GO:0001562) | 3.42134715 |
60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.40640957 |
61 | superoxide anion generation (GO:0042554) | 3.39955887 |
62 | cellular response to virus (GO:0098586) | 3.39931679 |
63 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.36634349 |
64 | positive regulation of type 2 immune response (GO:0002830) | 3.35111922 |
65 | myeloid cell activation involved in immune response (GO:0002275) | 3.33599210 |
66 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.32778018 |
67 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.31675426 |
68 | negative regulation of interleukin-17 production (GO:0032700) | 3.31627967 |
69 | reactive oxygen species biosynthetic process (GO:1903409) | 3.30879929 |
70 | cellular response to type I interferon (GO:0071357) | 3.30050608 |
71 | type I interferon signaling pathway (GO:0060337) | 3.30050608 |
72 | response to type I interferon (GO:0034340) | 3.28926137 |
73 | regulation of podosome assembly (GO:0071801) | 3.27655918 |
74 | cytokine secretion (GO:0050663) | 3.27428491 |
75 | positive regulation of antigen processing and presentation (GO:0002579) | 3.26094241 |
76 | negative regulation of lipid storage (GO:0010888) | 3.25611679 |
77 | regulation of T cell tolerance induction (GO:0002664) | 3.23814358 |
78 | macrophage activation (GO:0042116) | 3.23292117 |
79 | wound healing, spreading of epidermal cells (GO:0035313) | 3.19325948 |
80 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.17445248 |
81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.16721795 |
82 | positive regulation of humoral immune response (GO:0002922) | 3.15876462 |
83 | regulation of chemokine biosynthetic process (GO:0045073) | 3.15592564 |
84 | germinal center formation (GO:0002467) | 3.15092286 |
85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.13038244 |
86 | cellular extravasation (GO:0045123) | 3.12971496 |
87 | regulation of tolerance induction (GO:0002643) | 3.12767413 |
88 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.12387321 |
89 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.11623084 |
90 | myeloid dendritic cell differentiation (GO:0043011) | 3.11478805 |
91 | regulation of mononuclear cell migration (GO:0071675) | 3.10243355 |
92 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.08118927 |
93 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.06730281 |
94 | leukocyte cell-cell adhesion (GO:0007159) | 3.06720170 |
95 | regulation of antigen processing and presentation (GO:0002577) | 3.06672732 |
96 | regulation of heat generation (GO:0031650) | 3.05914367 |
97 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.04865631 |
98 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.03352215 |
99 | regulation of interleukin-17 production (GO:0032660) | 3.02051859 |
100 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.01882460 |
101 | leukocyte mediated cytotoxicity (GO:0001909) | 3.00431727 |
102 | negative regulation of T cell mediated immunity (GO:0002710) | 2.99486684 |
103 | positive regulation of mast cell degranulation (GO:0043306) | 2.99454441 |
104 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.99454441 |
105 | regulation of mast cell degranulation (GO:0043304) | 2.98884485 |
106 | regulation of vitamin metabolic process (GO:0030656) | 2.98029123 |
107 | regulation of interleukin-12 production (GO:0032655) | 2.97697729 |
108 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.97489778 |
109 | defense response to protozoan (GO:0042832) | 2.97210760 |
110 | low-density lipoprotein particle clearance (GO:0034383) | 2.97139162 |
111 | leukocyte aggregation (GO:0070486) | 2.97071180 |
112 | negative regulation of growth of symbiont in host (GO:0044130) | 2.96774785 |
113 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.96774785 |
114 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.96774785 |
115 | regulation of growth of symbiont in host (GO:0044126) | 2.96774785 |
116 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.96591531 |
117 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.96234978 |
118 | regulation of cholesterol storage (GO:0010885) | 2.95970027 |
119 | detection of other organism (GO:0098543) | 2.95373458 |
120 | interferon-gamma secretion (GO:0072643) | 2.95250524 |
121 | negative regulation of viral genome replication (GO:0045071) | 2.95136645 |
122 | B cell mediated immunity (GO:0019724) | 2.95066189 |
123 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.94914870 |
124 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.93647603 |
125 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.93524643 |
126 | regulation of gamma-delta T cell activation (GO:0046643) | 2.93213254 |
127 | detection of external biotic stimulus (GO:0098581) | 2.93068335 |
128 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.90669520 |
129 | regulation of chronic inflammatory response (GO:0002676) | 2.90598561 |
130 | cellular response to molecule of bacterial origin (GO:0071219) | 2.89761537 |
131 | cellular response to lipopolysaccharide (GO:0071222) | 2.88717136 |
132 | regulation of type 2 immune response (GO:0002828) | 2.87807199 |
133 | positive regulation of tolerance induction (GO:0002645) | 2.84829478 |
134 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.84767762 |
135 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.81601124 |
136 | myeloid dendritic cell activation (GO:0001773) | 2.80531542 |
137 | cellular response to interferon-gamma (GO:0071346) | 2.79031896 |
138 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.78542787 |
139 | lymphocyte chemotaxis (GO:0048247) | 2.76450274 |
140 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.75713165 |
141 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.74598664 |
142 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.72602740 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.63386557 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.34509882 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.22653850 |
4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.53724379 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.32014598 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.28507457 |
7 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.09760323 |
8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.66876400 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.61465929 |
10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.37930512 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.21374829 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.19648825 |
13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06123539 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.71129184 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.68744913 |
16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.63670679 |
17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.47443979 |
18 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.32550440 |
19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.32090002 |
20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26950816 |
21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23420993 |
22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.17752001 |
23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.10241078 |
24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93262917 |
25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.92010791 |
26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.89054161 |
27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.87430584 |
28 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.87336161 |
29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85656672 |
30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85292728 |
31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77824634 |
32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.75595697 |
33 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.68970910 |
34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62749697 |
35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62205469 |
36 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58365462 |
37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54804180 |
38 | MYC_22102868_ChIP-Seq_BL_Human | 1.52635300 |
39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51873883 |
40 | MAF_26560356_Chip-Seq_TH1_Human | 1.47370000 |
41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45098298 |
42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.43798070 |
43 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43350559 |
44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43011139 |
45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41610905 |
46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39878009 |
47 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.38848147 |
48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37470555 |
49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37216076 |
50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36898382 |
51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36527457 |
52 | MYB_26560356_Chip-Seq_TH2_Human | 1.35783241 |
53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33419059 |
54 | MAF_26560356_Chip-Seq_TH2_Human | 1.29467360 |
55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26997188 |
56 | MYB_26560356_Chip-Seq_TH1_Human | 1.26845293 |
57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26039537 |
58 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24026172 |
59 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23613339 |
60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22489641 |
61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21483920 |
62 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17494128 |
63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16995114 |
64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14684078 |
65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14497195 |
66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14010073 |
67 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12677921 |
68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06998979 |
69 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06285881 |
70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05901546 |
71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05169967 |
72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03974876 |
73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03310635 |
74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02808192 |
75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01585518 |
76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01024187 |
77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00204460 |
78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99536118 |
79 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.99392757 |
80 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99283736 |
81 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97542927 |
82 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97542927 |
83 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96721490 |
84 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95265885 |
85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94266371 |
86 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92204613 |
87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91808929 |
88 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91702836 |
89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91250936 |
90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90811993 |
91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90811993 |
92 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90805819 |
93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89191080 |
94 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89184028 |
95 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.89063895 |
96 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89033907 |
97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88632782 |
98 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88390282 |
99 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88247143 |
100 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87137952 |
101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86736180 |
102 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86254329 |
103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85889386 |
104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85214171 |
105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84903772 |
106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84591621 |
107 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.82912593 |
108 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82454874 |
109 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81699846 |
110 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81557784 |
111 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81482976 |
112 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81289498 |
113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81020896 |
114 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78466496 |
115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77628416 |
116 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77439545 |
117 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.75509305 |
118 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74388422 |
119 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.74219869 |
120 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.72523926 |
121 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72235650 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.86745690 |
2 | MP0009785_altered_susceptibility_to | 3.75075823 |
3 | MP0003436_decreased_susceptibility_to | 3.60208333 |
4 | MP0003303_peritoneal_inflammation | 3.53241383 |
5 | MP0000569_abnormal_digit_pigmentation | 3.53124333 |
6 | MP0004510_myositis | 3.28939212 |
7 | MP0002419_abnormal_innate_immunity | 3.16956342 |
8 | MP0009278_abnormal_bone_marrow | 3.12176690 |
9 | MP0002148_abnormal_hypersensitivity_rea | 3.03590051 |
10 | MP0005058_abnormal_lysosome_morphology | 2.97942625 |
11 | MP0005025_abnormal_response_to | 2.82887623 |
12 | MP0000685_abnormal_immune_system | 2.82462548 |
13 | MP0005000_abnormal_immune_tolerance | 2.82061570 |
14 | MP0006082_CNS_inflammation | 2.79383627 |
15 | MP0005387_immune_system_phenotype | 2.77599424 |
16 | MP0001790_abnormal_immune_system | 2.77599424 |
17 | MP0002452_abnormal_antigen_presenting | 2.48204864 |
18 | MP0003172_abnormal_lysosome_physiology | 2.47342639 |
19 | MP0004947_skin_inflammation | 2.36377370 |
20 | MP0002723_abnormal_immune_serum | 2.34172719 |
21 | MP0001800_abnormal_humoral_immune | 2.32588713 |
22 | MP0003724_increased_susceptibility_to | 2.27484802 |
23 | MP0005397_hematopoietic_system_phenotyp | 2.16000020 |
24 | MP0001545_abnormal_hematopoietic_system | 2.16000020 |
25 | MP0005451_abnormal_body_composition | 2.11060884 |
26 | MP0005464_abnormal_platelet_physiology | 2.10125790 |
27 | MP0001819_abnormal_immune_cell | 2.00852826 |
28 | MP0009764_decreased_sensitivity_to | 1.96922958 |
29 | MP0002420_abnormal_adaptive_immunity | 1.95711360 |
30 | MP0005671_abnormal_response_to | 1.93184069 |
31 | MP0001533_abnormal_skeleton_physiology | 1.85169827 |
32 | MP0003448_altered_tumor_morphology | 1.81249853 |
33 | MP0000343_altered_response_to | 1.77342699 |
34 | MP0008260_abnormal_autophagy | 1.76386429 |
35 | MP0001845_abnormal_inflammatory_respons | 1.73385192 |
36 | MP0001853_heart_inflammation | 1.72835397 |
37 | MP0002405_respiratory_system_inflammati | 1.69137627 |
38 | MP0008469_abnormal_protein_level | 1.68673275 |
39 | MP0005167_abnormal_blood-brain_barrier | 1.65865103 |
40 | MP0005174_abnormal_tail_pigmentation | 1.58917567 |
41 | MP0010155_abnormal_intestine_physiology | 1.57726509 |
42 | MP0008004_abnormal_stomach_pH | 1.55783731 |
43 | MP0003075_altered_response_to | 1.53634612 |
44 | MP0002998_abnormal_bone_remodeling | 1.51118079 |
45 | MP0002254_reproductive_system_inflammat | 1.49773018 |
46 | MP0009840_abnormal_foam_cell | 1.48542945 |
47 | MP0003183_abnormal_peptide_metabolism | 1.47324877 |
48 | MP0000604_amyloidosis | 1.43355216 |
49 | MP0005076_abnormal_cell_differentiation | 1.37830702 |
50 | MP0003300_gastrointestinal_ulcer | 1.36344059 |
51 | MP0000716_abnormal_immune_system | 1.36220160 |
52 | MP0002006_tumorigenesis | 1.32652683 |
53 | MP0000858_altered_metastatic_potential | 1.31268196 |
54 | MP0002398_abnormal_bone_marrow | 1.29363841 |
55 | MP0005083_abnormal_biliary_tract | 1.24645775 |
56 | MP0000015_abnormal_ear_pigmentation | 1.24303925 |
57 | MP0003763_abnormal_thymus_physiology | 1.22484795 |
58 | MP0003566_abnormal_cell_adhesion | 1.20404084 |
59 | MP0000371_diluted_coat_color | 1.18684331 |
60 | MP0003656_abnormal_erythrocyte_physiolo | 1.17984506 |
61 | MP0009763_increased_sensitivity_to | 1.15102393 |
62 | MP0000689_abnormal_spleen_morphology | 1.14452692 |
63 | MP0003091_abnormal_cell_migration | 1.14264034 |
64 | MP0002139_abnormal_hepatobiliary_system | 1.12427380 |
65 | MP0005166_decreased_susceptibility_to | 1.11740198 |
66 | MP0006054_spinal_hemorrhage | 1.11497670 |
67 | MP0005310_abnormal_salivary_gland | 1.10470280 |
68 | MP0003806_abnormal_nucleotide_metabolis | 1.08686411 |
69 | MP0002429_abnormal_blood_cell | 1.08094291 |
70 | MP0009333_abnormal_splenocyte_physiolog | 1.07558754 |
71 | MP0005257_abnormal_intraocular_pressure | 1.07259853 |
72 | MP0003453_abnormal_keratinocyte_physiol | 1.06837570 |
73 | MP0004883_abnormal_blood_vessel | 1.06185675 |
74 | MP0010307_abnormal_tumor_latency | 1.05119468 |
75 | MP0003191_abnormal_cellular_cholesterol | 1.01727963 |
76 | MP0002722_abnormal_immune_system | 0.98284016 |
77 | MP0002138_abnormal_hepatobiliary_system | 0.96295647 |
78 | MP0005164_abnormal_response_to | 0.95708315 |
79 | MP0003828_pulmonary_edema | 0.92271774 |
80 | MP0000465_gastrointestinal_hemorrhage | 0.91906107 |
81 | MP0004858_abnormal_nervous_system | 0.89910948 |
82 | MP0002166_altered_tumor_susceptibility | 0.87985976 |
83 | MP0001663_abnormal_digestive_system | 0.86972639 |
84 | MP0002332_abnormal_exercise_endurance | 0.86586020 |
85 | MP0005390_skeleton_phenotype | 0.85889698 |
86 | MP0001958_emphysema | 0.83669807 |
87 | MP0000249_abnormal_blood_vessel | 0.82505606 |
88 | MP0004808_abnormal_hematopoietic_stem | 0.82206299 |
89 | MP0003866_abnormal_defecation | 0.81320187 |
90 | MP0000767_abnormal_smooth_muscle | 0.81218738 |
91 | MP0002132_abnormal_respiratory_system | 0.80458637 |
92 | MP0003705_abnormal_hypodermis_morpholog | 0.77932907 |
93 | MP0003690_abnormal_glial_cell | 0.76622033 |
94 | MP0001851_eye_inflammation | 0.72491985 |
95 | MP0003195_calcinosis | 0.71831458 |
96 | MP0002877_abnormal_melanocyte_morpholog | 0.70952847 |
97 | MP0002933_joint_inflammation | 0.70584488 |
98 | MP0002277_abnormal_respiratory_mucosa | 0.70443907 |
99 | MP0008874_decreased_physiological_sensi | 0.69960223 |
100 | MP0004782_abnormal_surfactant_physiolog | 0.69631686 |
101 | MP0000703_abnormal_thymus_morphology | 0.67449488 |
102 | MP0003045_fibrosis | 0.67316177 |
103 | MP0005023_abnormal_wound_healing | 0.66693178 |
104 | MP0008438_abnormal_cutaneous_collagen | 0.65973571 |
105 | MP0003795_abnormal_bone_structure | 0.65320034 |
106 | MP0000490_abnormal_crypts_of | 0.64517042 |
107 | MP0001542_abnormal_bone_strength | 0.63482524 |
108 | MP0001873_stomach_inflammation | 0.62372588 |
109 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59409684 |
110 | MP0005165_increased_susceptibility_to | 0.59171057 |
111 | MP0002136_abnormal_kidney_physiology | 0.58427894 |
112 | MP0005621_abnormal_cell_physiology | 0.58058589 |
113 | MP0005535_abnormal_body_temperature | 0.57340662 |
114 | MP0000920_abnormal_myelination | 0.57069283 |
115 | MP0003186_abnormal_redox_activity | 0.56072894 |
116 | MP0003646_muscle_fatigue | 0.55784905 |
117 | MP0001191_abnormal_skin_condition | 0.55373304 |
118 | MP0005319_abnormal_enzyme/_coenzyme | 0.54816711 |
119 | MP0005197_abnormal_uvea_morphology | 0.53186943 |
120 | MP0009765_abnormal_xenobiotic_induced | 0.51981306 |
121 | MP0000609_abnormal_liver_physiology | 0.49964275 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 7.12768168 |
2 | Recurrent bacterial skin infections (HP:0005406) | 6.67021058 |
3 | Eczematoid dermatitis (HP:0000976) | 6.27033731 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.64274104 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.61425764 |
6 | Stomatitis (HP:0010280) | 5.58695846 |
7 | Mediastinal lymphadenopathy (HP:0100721) | 5.42479318 |
8 | Abnormality of macrophages (HP:0004311) | 5.21542867 |
9 | Autoimmune thrombocytopenia (HP:0001973) | 4.48610445 |
10 | Retrobulbar optic neuritis (HP:0100654) | 4.31586521 |
11 | Optic neuritis (HP:0100653) | 4.31586521 |
12 | Orchitis (HP:0100796) | 4.29969178 |
13 | Gingivitis (HP:0000230) | 4.16262172 |
14 | Recurrent skin infections (HP:0001581) | 4.14107304 |
15 | Increased cerebral lipofuscin (HP:0011813) | 4.09455391 |
16 | Myositis (HP:0100614) | 4.01384539 |
17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.86699844 |
18 | Vacuolated lymphocytes (HP:0001922) | 3.86225774 |
19 | Vasculitis (HP:0002633) | 3.78711767 |
20 | Recurrent fungal infections (HP:0002841) | 3.77833999 |
21 | Thick nail (HP:0001805) | 3.54801771 |
22 | Loss of speech (HP:0002371) | 3.50214120 |
23 | Periodontitis (HP:0000704) | 3.35949567 |
24 | Recurrent viral infections (HP:0004429) | 3.35795970 |
25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.35446538 |
26 | Obstructive lung disease (HP:0006536) | 3.35446538 |
27 | Amyloidosis (HP:0011034) | 3.34685442 |
28 | Prostate neoplasm (HP:0100787) | 3.23368753 |
29 | Premature loss of primary teeth (HP:0006323) | 3.15806279 |
30 | Increased IgE level (HP:0003212) | 3.12896076 |
31 | Urticaria (HP:0001025) | 3.12704604 |
32 | Pustule (HP:0200039) | 3.11895709 |
33 | Pulmonary infiltrates (HP:0002113) | 3.04033198 |
34 | Axonal loss (HP:0003447) | 3.00127142 |
35 | Encephalitis (HP:0002383) | 2.93538059 |
36 | Leukocytosis (HP:0001974) | 2.93086680 |
37 | Basal ganglia calcification (HP:0002135) | 2.92082747 |
38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90953490 |
39 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90953490 |
40 | Gangrene (HP:0100758) | 2.86696607 |
41 | Increased IgM level (HP:0003496) | 2.86340016 |
42 | Tetraparesis (HP:0002273) | 2.86026845 |
43 | Osteomyelitis (HP:0002754) | 2.68813079 |
44 | Systemic lupus erythematosus (HP:0002725) | 2.67158801 |
45 | Hematochezia (HP:0002573) | 2.64580531 |
46 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.63236542 |
47 | Bone pain (HP:0002653) | 2.61380067 |
48 | Arterial thrombosis (HP:0004420) | 2.59106649 |
49 | Spontaneous hematomas (HP:0007420) | 2.58856124 |
50 | Gingival bleeding (HP:0000225) | 2.57274880 |
51 | Frequent falls (HP:0002359) | 2.56394687 |
52 | Cellulitis (HP:0100658) | 2.52026959 |
53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.50880451 |
54 | T lymphocytopenia (HP:0005403) | 2.50083962 |
55 | Vertebral compression fractures (HP:0002953) | 2.48041853 |
56 | Myocardial infarction (HP:0001658) | 2.46767062 |
57 | Keratoconjunctivitis sicca (HP:0001097) | 2.44974918 |
58 | Abnormality of T cell number (HP:0011839) | 2.41548286 |
59 | Chest pain (HP:0100749) | 2.41008112 |
60 | Pulmonary embolism (HP:0002204) | 2.35716108 |
61 | Abnormality of the pleura (HP:0002103) | 2.31685383 |
62 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31430864 |
63 | Osteolytic defects of the hand bones (HP:0009699) | 2.31430864 |
64 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.30849071 |
65 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.30849071 |
66 | Abnormality of glycolipid metabolism (HP:0010969) | 2.30849071 |
67 | Meningitis (HP:0001287) | 2.30692600 |
68 | Pathologic fracture (HP:0002756) | 2.29942291 |
69 | Malnutrition (HP:0004395) | 2.27936861 |
70 | Glomerulonephritis (HP:0000099) | 2.27555664 |
71 | Mutism (HP:0002300) | 2.25503145 |
72 | Pulmonary artery stenosis (HP:0004415) | 2.23938831 |
73 | Purpura (HP:0000979) | 2.22729269 |
74 | Abnormality of iron homeostasis (HP:0011031) | 2.22499446 |
75 | Hemoptysis (HP:0002105) | 2.22294334 |
76 | Keratoconjunctivitis (HP:0001096) | 2.21381684 |
77 | Restrictive lung disease (HP:0002091) | 2.18601838 |
78 | Chronic otitis media (HP:0000389) | 2.16154364 |
79 | Vertigo (HP:0002321) | 2.15189029 |
80 | Dysostosis multiplex (HP:0000943) | 2.15006116 |
81 | Hypergammaglobulinemia (HP:0010702) | 2.14365581 |
82 | Joint hemorrhage (HP:0005261) | 2.14133325 |
83 | Hepatosplenomegaly (HP:0001433) | 2.13830153 |
84 | Petechiae (HP:0000967) | 2.13320866 |
85 | Disinhibition (HP:0000734) | 2.13078487 |
86 | Abnormality of the endocardium (HP:0004306) | 2.12943910 |
87 | Acne (HP:0001061) | 2.11797481 |
88 | Colitis (HP:0002583) | 2.11522706 |
89 | Autoimmune hemolytic anemia (HP:0001890) | 2.11249367 |
90 | Recurrent pneumonia (HP:0006532) | 2.10834990 |
91 | Episodic fever (HP:0001954) | 2.10657745 |
92 | Tetany (HP:0001281) | 2.08865659 |
93 | Gastrointestinal infarctions (HP:0005244) | 2.07879246 |
94 | Neurofibrillary tangles (HP:0002185) | 2.07851088 |
95 | Nuclear cataract (HP:0100018) | 2.06314107 |
96 | Glomerulopathy (HP:0100820) | 2.06164752 |
97 | Abnormality of the pericardium (HP:0001697) | 2.05999253 |
98 | Inflammation of the large intestine (HP:0002037) | 2.04942997 |
99 | Esophageal neoplasm (HP:0100751) | 2.04002636 |
100 | Neoplasm of head and neck (HP:0012288) | 2.04002636 |
101 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.03907207 |
102 | Interstitial pulmonary disease (HP:0006530) | 2.03814998 |
103 | Porencephaly (HP:0002132) | 2.02794921 |
104 | Prolonged bleeding time (HP:0003010) | 2.02683616 |
105 | Arthralgia (HP:0002829) | 2.01877509 |
106 | Turricephaly (HP:0000262) | 2.01539854 |
107 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01098070 |
108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01098070 |
109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01098070 |
110 | Absent frontal sinuses (HP:0002688) | 2.00291569 |
111 | Progressive neurologic deterioration (HP:0002344) | 1.98213637 |
112 | Keratitis (HP:0000491) | 1.97853675 |
113 | Nephritis (HP:0000123) | 1.96924236 |
114 | Hypophosphatemia (HP:0002148) | 1.96805880 |
115 | Progressive sensorineural hearing impairment (HP:0000408) | 1.96271160 |
116 | Neuronal loss in central nervous system (HP:0002529) | 1.95418558 |
117 | Gastrointestinal inflammation (HP:0004386) | 1.95066101 |
118 | Joint swelling (HP:0001386) | 1.94977351 |
119 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.94781838 |
120 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94636396 |
121 | Mucopolysacchariduria (HP:0008155) | 1.94636396 |
122 | Increased serum ferritin (HP:0003281) | 1.93610805 |
123 | Gastrointestinal stroma tumor (HP:0100723) | 1.93539552 |
124 | Peritonitis (HP:0002586) | 1.92337582 |
125 | Submucous cleft hard palate (HP:0000176) | 1.90232095 |
126 | Progressive hearing impairment (HP:0001730) | 1.88385405 |
127 | Epistaxis (HP:0000421) | 1.88014698 |
128 | Anorexia (HP:0002039) | 1.85703500 |
129 | Recurrent lower respiratory tract infections (HP:0002783) | 1.85158293 |
130 | Albinism (HP:0001022) | 1.83630311 |
131 | Nausea (HP:0002018) | 1.83466536 |
132 | Polyneuropathy (HP:0001271) | 1.81488711 |
133 | Eosinophilia (HP:0001880) | 1.81002456 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 5.30594808 |
2 | RIPK4 | 4.88831401 |
3 | IRAK3 | 4.74033017 |
4 | TBK1 | 4.01757340 |
5 | IKBKE | 3.65109793 |
6 | IRAK4 | 3.27786888 |
7 | TYK2 | 3.15648126 |
8 | IKBKB | 2.69555029 |
9 | MAP3K13 | 2.55555104 |
10 | JAK3 | 2.50507340 |
11 | BLK | 2.38073036 |
12 | JAK1 | 2.10279711 |
13 | KIT | 2.09962467 |
14 | TAOK1 | 2.08216510 |
15 | GRK7 | 2.03902244 |
16 | MAP4K1 | 1.96487500 |
17 | CHUK | 1.96119917 |
18 | TXK | 1.84199178 |
19 | PBK | 1.74591026 |
20 | RPS6KA4 | 1.60524534 |
21 | DDR2 | 1.58684420 |
22 | ERN1 | 1.55931584 |
23 | PIM2 | 1.53479739 |
24 | TAOK3 | 1.44738738 |
25 | TTN | 1.37416273 |
26 | CDC42BPA | 1.37335831 |
27 | DAPK2 | 1.25814460 |
28 | CSK | 1.24611270 |
29 | FGR | 1.24184215 |
30 | PIM1 | 1.19394545 |
31 | TNK2 | 1.17368320 |
32 | PTK6 | 1.14090139 |
33 | MST4 | 1.12159125 |
34 | HCK | 1.09920767 |
35 | JAK2 | 1.08090682 |
36 | SYK | 1.05886333 |
37 | MARK3 | 1.05446225 |
38 | EPHB1 | 1.04161888 |
39 | NME2 | 1.03446319 |
40 | EIF2AK2 | 1.02384648 |
41 | ZAP70 | 1.02252676 |
42 | LCK | 0.96698572 |
43 | BMX | 0.94207675 |
44 | MAP3K10 | 0.94134632 |
45 | SIK2 | 0.93335996 |
46 | ABL2 | 0.90752817 |
47 | LYN | 0.87920169 |
48 | MAP3K5 | 0.86454541 |
49 | DAPK3 | 0.82555937 |
50 | GRK6 | 0.81443283 |
51 | RIPK1 | 0.81391038 |
52 | NEK9 | 0.80599704 |
53 | STK4 | 0.80265744 |
54 | CSF1R | 0.79937717 |
55 | EPHA3 | 0.77627463 |
56 | EGFR | 0.77171302 |
57 | FES | 0.76967268 |
58 | YES1 | 0.75695343 |
59 | BTK | 0.74152286 |
60 | MAP2K3 | 0.73647759 |
61 | TGFBR2 | 0.71678671 |
62 | MATK | 0.71205005 |
63 | MST1R | 0.69508582 |
64 | MARK2 | 0.69191069 |
65 | TAOK2 | 0.66650738 |
66 | ABL1 | 0.66122912 |
67 | TRPM7 | 0.65506459 |
68 | IRAK2 | 0.63902954 |
69 | SIK3 | 0.63407114 |
70 | CDK12 | 0.62737318 |
71 | HIPK2 | 0.60581711 |
72 | KSR2 | 0.58483405 |
73 | MAP3K3 | 0.58201843 |
74 | BMPR2 | 0.56598252 |
75 | CAMK1D | 0.55549662 |
76 | PRKD2 | 0.54212235 |
77 | STK3 | 0.53662088 |
78 | PRKCD | 0.52782822 |
79 | ERBB4 | 0.52513145 |
80 | MAPK7 | 0.51659540 |
81 | TESK2 | 0.50656635 |
82 | RPS6KA6 | 0.47472463 |
83 | TEC | 0.47003748 |
84 | TRIB3 | 0.46673117 |
85 | MAP2K6 | 0.45970462 |
86 | STK10 | 0.45866210 |
87 | PDPK1 | 0.45656465 |
88 | CDK6 | 0.44905707 |
89 | SIK1 | 0.44791931 |
90 | IRAK1 | 0.44167637 |
91 | MAP3K11 | 0.43893387 |
92 | PDGFRB | 0.42461224 |
93 | ADRBK2 | 0.39983811 |
94 | PDK1 | 0.36647851 |
95 | SMG1 | 0.36088668 |
96 | MAP3K6 | 0.35982225 |
97 | ITK | 0.34089493 |
98 | DYRK3 | 0.33872274 |
99 | DYRK1B | 0.32336885 |
100 | SGK1 | 0.32034953 |
101 | MAPKAPK2 | 0.31241542 |
102 | MAPK4 | 0.31012173 |
103 | LRRK2 | 0.30583508 |
104 | RPS6KA2 | 0.30446228 |
105 | CAMK1G | 0.30093625 |
106 | FGFR4 | 0.29844234 |
107 | FYN | 0.29725094 |
108 | CLK1 | 0.28946359 |
109 | MAP3K7 | 0.28504584 |
110 | PRKG2 | 0.28485074 |
111 | ACVR1B | 0.26703095 |
112 | PAK4 | 0.26470412 |
113 | ERBB2 | 0.25979315 |
114 | MAP3K1 | 0.25560530 |
115 | MAPK12 | 0.25105931 |
116 | MOS | 0.24203300 |
117 | PRKCQ | 0.23719597 |
118 | NTRK1 | 0.23692272 |
119 | RPS6KC1 | 0.23641738 |
120 | RPS6KL1 | 0.23641738 |
121 | GSK3A | 0.22622785 |
122 | ERBB3 | 0.20748792 |
123 | PRPF4B | 0.20615968 |
124 | DAPK1 | 0.20187699 |
125 | PKN1 | 0.19767749 |
126 | FGFR3 | 0.19464226 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.34776127 |
2 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 3.05132915 |
3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.92522574 |
4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.88101635 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.82339460 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55930737 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.53084082 |
8 | Malaria_Homo sapiens_hsa05144 | 2.49691790 |
9 | Legionellosis_Homo sapiens_hsa05134 | 2.45478450 |
10 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.45186181 |
11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.43684342 |
12 | Pertussis_Homo sapiens_hsa05133 | 2.37149181 |
13 | Allograft rejection_Homo sapiens_hsa05330 | 2.36111649 |
14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.34068051 |
15 | Tuberculosis_Homo sapiens_hsa05152 | 2.28389690 |
16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.23362527 |
17 | Measles_Homo sapiens_hsa05162 | 2.12868862 |
18 | Influenza A_Homo sapiens_hsa05164 | 2.03901313 |
19 | Asthma_Homo sapiens_hsa05310 | 1.85626949 |
20 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.84327540 |
21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81230812 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79626613 |
23 | Phagosome_Homo sapiens_hsa04145 | 1.67323172 |
24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64563854 |
25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.57120544 |
26 | Apoptosis_Homo sapiens_hsa04210 | 1.55656026 |
27 | Lysosome_Homo sapiens_hsa04142 | 1.54949256 |
28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51944061 |
29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51932798 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.48463228 |
31 | Shigellosis_Homo sapiens_hsa05131 | 1.43706810 |
32 | Salmonella infection_Homo sapiens_hsa05132 | 1.42795602 |
33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35485437 |
34 | Hepatitis C_Homo sapiens_hsa05160 | 1.28131006 |
35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27099155 |
36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24759073 |
37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20012009 |
38 | Hepatitis B_Homo sapiens_hsa05161 | 1.18227486 |
39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15946827 |
40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13963684 |
41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.13839501 |
42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12543709 |
43 | Amoebiasis_Homo sapiens_hsa05146 | 1.09865719 |
44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09267940 |
45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03978202 |
46 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96838087 |
47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96100259 |
48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95663929 |
49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94970118 |
50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90496219 |
51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88826064 |
52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88595929 |
53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87393223 |
54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84529161 |
55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82737519 |
56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82253272 |
57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82054013 |
58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81401959 |
59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78174058 |
60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77973380 |
61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76717063 |
62 | Bladder cancer_Homo sapiens_hsa05219 | 0.74639190 |
63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71526561 |
64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68439018 |
65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66909817 |
66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66612499 |
67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64716142 |
68 | Insulin resistance_Homo sapiens_hsa04931 | 0.59124840 |
69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57255132 |
70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56605208 |
71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55321377 |
72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54616367 |
73 | Platelet activation_Homo sapiens_hsa04611 | 0.54507522 |
74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52063070 |
75 | Endocytosis_Homo sapiens_hsa04144 | 0.48587179 |
76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46425708 |
77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43677383 |
78 | Prion diseases_Homo sapiens_hsa05020 | 0.43628090 |
79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42516118 |
80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41974884 |
81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41384123 |
82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40612459 |
83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39905490 |
84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39246982 |
85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39231052 |
86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37066104 |
87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36425488 |
88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36402605 |
89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34630205 |
90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34287601 |
91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32996591 |
92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32543218 |
93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30363410 |
94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29893305 |
95 | Prostate cancer_Homo sapiens_hsa05215 | 0.26531809 |
96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25927179 |
97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25594527 |
98 | ABC transporters_Homo sapiens_hsa02010 | 0.25515623 |
99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25154703 |
100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.25150802 |
101 | Focal adhesion_Homo sapiens_hsa04510 | 0.24524881 |
102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24076683 |
103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23359823 |
104 | Mineral absorption_Homo sapiens_hsa04978 | 0.21308069 |
105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20279961 |
106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.20272228 |
107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20081768 |
108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.19090487 |
109 | Glioma_Homo sapiens_hsa05214 | 0.18991616 |
110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.17117180 |
111 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.15107336 |
112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13589975 |
113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.12224146 |
114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.10653992 |